Can above-optimal ferritin with fatty-acid imbalance indicate low-grade inflammation?

Elevated serum ferritin paired with a fatty acid imbalance serves as a powerful biomarker profile reflecting systemic, low-grade metabolic inflammation.

Clinical evidence

• Metabolic Hyperferritinemia: Above-optimal serum ferritin, occurring independently of true body iron stores, is a classic feature of metabolic syndrome, insulin resistance, and non-alcoholic fatty liver disease (NAFLD).
• Pro-inflammatory Lipid Tone: An elevated omega-6 to omega-3 or arachidonic acid to eicosapentaenoic acid (AA/EPA) ratio shifts the systemic environment toward chronic inflammation by favoring the production of pro-inflammatory eicosanoids, such as prostaglandins and leukotrienes.

Mechanistic explanations

• Cytokine-Driven Synthesis: Pro-inflammatory cytokines drive ferritin synthesis. Interleukin-6 (IL-6) activates the hepatic JAK-STAT3 pathway to promote transcription, while TNF-α stimulates NF-κB to upregulate ferritin heavy (H) chain transcription.
• Active Inflammatory Loop: Ferritin is not merely a passive marker; it acts as an active mediator that stimulates NF-κB signaling to increase the expression of IL-6, TNF-α, and IL-1β, creating a pro-inflammatory feed-forward loop.
• Oxidative Stress and Lipid Binding: Cytokine-induced hepcidin elevation degrades ferroportin, trapping iron intracellularly. This sequestered iron participates in Fenton chemistry, generating hydroxyl radicals that cause lipid peroxidation of abundant polyunsaturated fatty acids like AA. Under metabolic stress, AA binds directly to inter-subunit pockets of ferritin to alter iron mineralization, a critical buffering system that leads to ferroptosis and tissue damage when overwhelmed.

Bottom line

• Above-optimal ferritin and a high AA/EPA ratio synergistically confirm a low-grade inflammatory signaling pattern, driven by cytokine-induced acute-phase responses, active NF-κB feedback loops, and heightened lipid peroxidation.